Fever Tree: US History and Opportunity
Former Vice President of Fever Tree
inpractise.com/articles/fever-tree-us-history-and-opportunity
Fever Tree: US History and Opportunity(August 21, 2023)
Former Vice President of Fever Tree
Interview Transcript
This is a snippet of the transcript, sign up to read more.
We've touched on tequila. Are there other adjustments you would make to the on-premise strategy that could potentially drive higher organic growth?
I believe a more specific pricing strategy for the channel would be beneficial. In the West, we managed to match our cost per ounce to that of Schweppes or Goslings, ensuring that pricing would not be a barrier. We would set a price and say, if you're willing to use four different types of Fever-Tree and meet certain thresholds, we'll offer you our best price. We used this as a negotiation tactic, but it was never adopted at a national level. I would propose discussing that. A strategy like this could be helpful.
This is a snippet of the transcript, sign up to read more.
Where do you see the most significant improvement?
The main areas are speed of service and distance. If you have a copacker in a market and discover there's cardboard and glass availability within 500 miles, you're gaining a compounding benefit.
This is a snippet of the transcript, sign up to read more.
Related Content
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.